semaglutide pediatric approval GLP-1 prescribing among teens with obesity Novo says it's submitted obesity

The increased need for facial volume restoration after GLP-1RA-induced weight loss has made corrective aesthetic procedures more popular, including dermal fillers, biostimulatory agents, skin-tightening treatments, and energy-based devices to address fat depletion effects [54]

Wegovy Consumer Website: Pen Results

FDA Approval Timeline: From NDA to Market Launch NDA Submission: Q4 2026 Eli Lilly will compile efficacy data primarily from TRIUMPH-1, supportive data from TRIUMPH-4, the safety database across all trials, and manufacturing/labeling documentation

However, some patients report sleep disturbances that may occur indirectly through gastrointestinal symptoms, blood glucose changes, or metabolic adjustments

Ducastel S, Touche V, Trabelsi MS, Boulinguiez A, Butruille L, Nawrot M, Peschard S, Chvez-Talavera O, Dorchies E, Vallez E, Annicotte JS, Lancel S, Briand O, Bantubungi K, Caron S, Bindels LB, Delzenne NM, Tailleux A, Staels B, Lestavel S